Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
Systemic amyloidosis is a fatal disorder caused by pathological extracellular deposits of amyloid fibrils that are always coated with the normal plasma protein, serum amyloid P component (SAP). The small-molecule drug, miridesap, [(R)-1-[6-[(R)-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl]pyrrolidine-2...
Hoofdauteurs: | Richards, D, Cookson, L, Barton, S, Liefaard, L, Lane, T, Hutt, D, Ritter, J, Fontana, M, Moon, J, Gillmore, J, Wechalekar, A, Hawkins, P, Pepys, M |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
American Association for the Advancement of Science
2018
|
Gelijkaardige items
-
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
door: Nelson, SR, et al.
Gepubliceerd in: (1991) -
Amyloid and amyloidosis /
door: Skinner, Martha, et al.
Gepubliceerd in: (2005) -
Native T1 mapping in transthyretin amyloidosis
door: Fontana, M, et al.
Gepubliceerd in: (2014) -
Native T1 mapping in transthyretin amyloidosis.
door: Fontana, M, et al.
Gepubliceerd in: (2014) -
Eyelid Amyloid Deposition in Systemic Light Chain Amyloidosis
door: R. Bouceiro-Mendes, et al.
Gepubliceerd in: (2022-03-01)